DB Alex. Brown Keeps 'Neutral' on Bristol-Myers

Analyst Barbara Ryan says the drug maker's news that wholesale inventories are too high is not a new issue

Deutsche Banc Alex. Brown keeps it neutral rating on Bristol-Myers (BMY ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.